Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4308047 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| Tetraethylene Glycol SCHEMBL22614779 | 0.88 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL8634087 | 0.88 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL1987972 | 0.88 | LMNA (0.32) | — | |
| Di(Hydroxyethyl)Ether SCHEMBL5580116 | 0.85 | TSHR (0.56) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL440997 | 0.85 | — | — | |
| SCHEMBL30753573 | 0.85 | — | — | |
| SCHEMBL28788474 | 0.84 | MEN1 (0.52) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL7502957 | 0.83 | TSHR (0.53) | MEN1KMT2ATSHRMAPK1THRB | |
| Alcohol SCHEMBL9067602 | 0.81 | ALDH1A1 (0.36) | TSHRMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11725078-B2 | Method for producing acid-decomposable polymer | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2023-08-15 | — | — | US | disclosed |
| US-20140249105-A1 | NOVEL CERAMIDE ANALOGUES, PROCESSES FOR PREPARING SAME AND USES THEREOF | DIVERCHIM (FR) | 2014-09-04 | — | — | US | disclosed |
| EP-0281912-B1 | CURABLE HYDROPHILIC SILICONE POLYETHER POLYMER | GENERAL ELECTRIC COMPANY (US) | 1992-05-20 | — | — | EP | disclosed |
| US-4859529-A | BIS(ALKOXYSILYL)POLYETHER | GENERAL ELECTRIC CO. (US) | 1989-08-22 | — | — | US | disclosed |
| EP-0281912-A1 | Curable hydrophilic silicone polyether polymer | GENERAL ELECTRIC COMPANY (US) | 1988-09-14 | — | — | EP | disclosed |
| US-4758646-A | Curable hydrophilic silicone polyether polymer | GENERAL ELECTRIC COMPANY (US) | 1988-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249105-A1 | NOVEL CERAMIDE ANALOGUES, PROCESSES FOR PREPARING SAME AND USES THEREOF | CERS2, CERT1, SGMS2 | MEN1 1458/4885KMT2A 3589/4885TSHR 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.